Cite
HARVARD Citation
Reyes, R. et al. (n.d.). 719 CD122-directed interleukin-2 complexes and αPD-L1 differentially require innate and adaptive immunity to treat local and metastatic bladder cancer. Journal for immunotherapy of cancer. p. A761. [Online].